Assessment of the efficacy of novel inhibitors against pancreatic cancer

Forschungsstelle

INNOSUISSE

Projektnummer

40922.1 IP-LS

Projekttitel

Assessment of the efficacy of novel inhibitors against pancreatic cancer

Projekttitel Englisch

Assessment of the efficacy of novel inhibitors against pancreatic cancer

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Kurzbeschreibung		-	-
Abstract		-	-	-

Kategorie	Text
Kurzbeschreibung (Deutsch)	Assessment of the efficacy of novel inhibitors against pancreatic cancer
Kurzbeschreibung (Englisch)	Assessment of the efficacy of novel inhibitors against pancreatic cancer
Abstract (Deutsch)	Pancreatic cancer (PDAC) is marked by rich desmoplastic stroma and immunosuppression. The proposed project will deliver mechanistic information and efficacy data of two novel inhibitors of PDAC, providing a strong rationale for entering clinical studies in PDAC patients with these therapeutics.